These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
483 related items for PubMed ID: 20471131
1. EASL clinical practice guidelines for HFE hemochromatosis. European Association For The Study Of The Livereasl@easloffice.eu. J Hepatol; 2010 Jul; 53(1):3-22. PubMed ID: 20471131 [Abstract] [Full Text] [Related]
3. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening. Barton JC, Acton RT, Leiendecker-Foster C, Lovato L, Adams PC, McLaren GD, Eckfeldt JH, McLaren CE, Reboussin DM, Gordeuk VR, Speechley MR, Reiss JA, Press RD, Dawkins FW, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. Genet Test; 2007 Apr 15; 11(3):269-75. PubMed ID: 17949288 [Abstract] [Full Text] [Related]
4. Non-HFE hemochromatosis. Pietrangelo A. Semin Liver Dis; 2005 Nov 15; 25(4):450-60. PubMed ID: 16315138 [Abstract] [Full Text] [Related]
5. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis. Aguilar-Martinez P, Esculié-Coste C, Bismuth M, Giansily-Blaizot M, Larrey D, Schved JF. Blood Cells Mol Dis; 2001 Nov 15; 27(1):290-3. PubMed ID: 11358390 [Abstract] [Full Text] [Related]
6. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis. Gleeson F, Ryan E, Barrett S, Russell J, Crowe J. Blood Cells Mol Dis; 2007 Nov 15; 38(1):37-44. PubMed ID: 17098454 [Abstract] [Full Text] [Related]
7. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study. Adams PC, Pankow JS, Barton JC, Acton RT, Leiendecker-Foster C, McLaren GD, Speechley M, Eckfeldt JH. Circ Cardiovasc Genet; 2009 Feb 15; 2(1):34-7. PubMed ID: 20031565 [Abstract] [Full Text] [Related]
8. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasit V, Miller A, McHugh PJ, Chapman RW, Pointon JJ, Wimhurst VL, Livesey KJ, Tanphaichitr V, Rochette J, Robson KJ. Hum Mol Genet; 2003 Sep 01; 12(17):2241-7. PubMed ID: 12915468 [Abstract] [Full Text] [Related]
9. [Hereditary and acquired iron overload]. de Korwin JD. Nephrol Ther; 2006 Nov 01; 2 Suppl 5():S304-12. PubMed ID: 17373275 [Abstract] [Full Text] [Related]
10. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis. Del-Castillo-Rueda A, Moreno-Carralero MI, Cuadrado-Grande N, Alvarez-Sala-Walther LA, Enríquez-de-Salamanca R, Méndez M, Morán-Jiménez MJ. Gene; 2012 Oct 15; 508(1):15-20. PubMed ID: 22890139 [Abstract] [Full Text] [Related]
11. Iron overload and prolonged ingestion of iron supplements: clinical features and mutation analysis of hemochromatosis-associated genes in four cases. Barton JC, Lee PL, West C, Bottomley SS. Am J Hematol; 2006 Oct 15; 81(10):760-7. PubMed ID: 16838333 [Abstract] [Full Text] [Related]
12. [Molecular genetic diagnostics and screening of hereditary hemochromatosis]. Zlocha J, Kovács L, Pozgayová S, Kupcová V, Durínová S. Vnitr Lek; 2006 Jun 15; 52(6):602-8. PubMed ID: 16871764 [Abstract] [Full Text] [Related]
13. Non-classical hereditary hemochromatosis in Portugal: novel mutations identified in iron metabolism-related genes. Mendes AI, Ferro A, Martins R, Picanço I, Gomes S, Cerqueira R, Correia M, Nunes AR, Esteves J, Fleming R, Faustino P. Ann Hematol; 2009 Mar 15; 88(3):229-34. PubMed ID: 18762941 [Abstract] [Full Text] [Related]
14. Hemochromatosis and iron-overload screening in a racially diverse population. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. N Engl J Med; 2005 Apr 28; 352(17):1769-78. PubMed ID: 15858186 [Abstract] [Full Text] [Related]
15. A primer for predicting risk of disease in HFE-linked hemochromatosis. Adams PC, Walker AP, Acton RT. Genet Test; 2001 Apr 28; 5(4):311-6. PubMed ID: 11960576 [Abstract] [Full Text] [Related]
16. Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload. Badar S, Busti F, Ferrarini A, Xumerle L, Bozzini P, Capelli P, Pozzi-Mucelli R, Campostrini N, De Matteis G, Marin Vargas S, Giorgetti A, Delledonne M, Olivieri O, Girelli D. Am J Hematol; 2016 Jun 28; 91(4):420-5. PubMed ID: 26799139 [Abstract] [Full Text] [Related]
17. Iron-overload-related disease in HFE hereditary hemochromatosis. Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, Anderson GJ, Southey MC, Giles GG, English DR, Hopper JL, Olynyk JK, Powell LW, Gertig DM. N Engl J Med; 2008 Jan 17; 358(3):221-30. PubMed ID: 18199861 [Abstract] [Full Text] [Related]
18. [Iron in the era of molecular biology]. Deugnier Y, Moirand R, Brissot P, David V. Pathol Biol (Paris); 1999 Nov 17; 47(9):938-44. PubMed ID: 10609274 [Abstract] [Full Text] [Related]
19. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Pietrangelo A. Gastroenterology; 2010 Aug 17; 139(2):393-408, 408.e1-2. PubMed ID: 20542038 [Abstract] [Full Text] [Related]
20. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population. Wrede CE, Hutzler S, Bollheimer LC, Buettner R, Hellerbrand C, Schöelmerich J, Palitzsch KD. Isr Med Assoc J; 2004 Jan 17; 6(1):30-3. PubMed ID: 14740507 [Abstract] [Full Text] [Related] Page: [Next] [New Search]